Revolution Medici…
USUSDRevolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Número de bolsas en las que cotizan las acciones de la empresa: 1. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la empresa
- Sitio web
- revmed.com
- Relaciones con los inversores
- revmed.com/investors/
- Sector
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Sede central
- REDWOOD CITY, United States
- Consejero delegado
- Dr. Mark A. Goldsmith M.D., Ph.D.
- Empleados
- 883
- Fundada
- 2014
- Acciones en circulación
- 214.34 M a 2026-07-31
- Capital flotante
- 184.5 M
- Capitalización bursátil
- 43.24 mil M USD
- Insiders
- 1.85%
- Inversores institucionales
- 101.01%
- Industria (SIC)
- Biological Products, (No Diagnostic Substances)
- ISIN
- US76155X1000
- LEI
- 549300JU3X0LBCQ65892
Descripción
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Bolsas y tickers
| Bolsa | Ticker | Moneda | Precio | Tipo |
|---|---|---|---|---|
| US USA Stocks | RVMD | USD | 199.87 -3.76% | acciones ordinarias |
Dividendos
No se han encontrado pagos de dividendos (comprobado el 07.10.2026). Es probable que la empresa no reparta dividendos.
Noticias de esta semana
Aún no hay noticias del sitio web de la empresa.
Principales accionistas
| Titular | Participación | Acciones | Fecha del informe |
|---|---|---|---|
| Blackrock Inc. | 6.39% | 13.7 M | 2026-06-30 |
| Farallon Capital Managem… | 6.32% | 13.55 M | 2026-06-30 |
| FMR, LLC | 5.69% | 12.2 M | 2026-06-30 |
| Baker Bros. Advisors, LP | 5.34% | 11.44 M | 2026-06-30 |
| Jupiter Topco LLC | 5.01% | 10.74 M | 2026-06-30 |
| Darwin Global Management… | 4.96% | 10.63 M | 2026-06-30 |
| Vanguard Capital Managem… | 4.24% | 9.09 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.87% | 8.29 M | 2026-06-30 |
| Nextech Invest, Ltd. | 3.55% | 7.6 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.99% | 6.41 M | 2026-06-30 |
| Paradigm Biocapital Advi… | 2.97% | 6.36 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.16% | 4.63 M | 2026-06-30 |
| Growth Fund of America | 1.38% | 2.96 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.25% | 2.67 M | 2026-06-30 |
| Fidelity Mt. Vernon Stre… | 1.15% | 2.47 M | 2026-07-31 |
| BORISY ALEXIS (Director) | ≈1.09% | 2.34 M | 2026-06-18 |
| VANGUARD INDEX FUNDS-Van… | 1.07% | 2.29 M | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.86% | 1.84 M | 2026-04-30 |
| iShares Trust-iShares Bi… | 0.65% | 1.39 M | 2026-07-31 |
| JPMorgan Trust II-JPMorg… | 0.54% | 1.17 M | 2026-06-30 |
| iShares Trust-iShares Ru… | 0.51% | 1.1 M | 2026-07-31 |
| GOLDSMITH MARK A (Chief… | ≈0.46% | 984 238 | 2026-08-21 |
| KELSEY STEPHEN MICHAEL (… | ≈0.14% | 291 876 | 2026-09-11 |
| HORN MARGARET A (Chief O… | ≈0.07% | 154 647 | 2026-06-17 |
| ANDERS JACK LEE (Chief F… | ≈0.06% | 123 269 | 2026-06-24 |
| WANG XIAOLIN (Officer) | ≈0.05% | 116 063 | 2026-03-17 |
| LIN WEI (Officer) | ≈0.05% | 101 366 | 2026-03-17 |
| HORNING SANDRA (Director… | ≈0.05% | 97 765 | 2026-06-18 |
| CISLINI JEFFREY TODD (Ge… | ≈0.03% | 55 907 | 2026-08-21 |
| SCHROEDER THILO (Directo… | — | — | 2024-12-05 |
